Skip to main content
. Author manuscript; available in PMC: 2022 Nov 19.
Published in final edited form as: JAMA Health Forum. 2021 Nov 19;2(11):e213833. doi: 10.1001/jamahealthforum.2021.3833

Figure 3.

Figure 3.

State Policies Influencing Opioid Use Disorder Treatment During the COVID-19 Pandemic

DEA Indicates US Drug Enforcement Administration; OTP, opioid treatment program; SAMHSA, Substance Abuse and Mental Health Services Administration. States in the outermost layer under the title “behavioral health facilitated via telehealth” include those that enacted all 3 of the following policies: telehealth coverage for behavioral health, waiver of requirement for established clinician-patient relationship for telehealth, and waiver of requirement for prior in-person contact for telehealth.